← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 1, 2013Last known activity
Feb 4, 2019
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 2 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Studied for
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lymphoma
- Multiple Myeloma
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Recurrence
- Syndrome
Recent trials (2)
- NCT03852407CollaboratorPhase 3Feb 4, 2019
- NCT02017457CollaboratorPhase 2Dec 1, 2013
Details
- Last known activity
- Feb 4, 2019